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The current study investigates the neurotrophic effects of Clostridium botulinum
C3 transferase (C3bot) on highly purified, glia-free, GABAergic, and glutamatergic
neurons. Incubation with nanomolar concentrations of C3bot promotes dendrite
formation as well as dendritic and axonal outgrowth in rat GABAergic neurons. A
comparison of C3bot effects on sorted mouse GABAergic and glutamatergic neurons
obtained from newly established NexCre;Ai9xVGAT Venus mice revealed a higher
sensitivity of GABAergic cells to axonotrophic and dendritic effects of C3bot in terms
of process length and branch formation. Protein biochemical analysis of known C3bot
binding partners revealed comparable amounts of β1 integrin in both cell types but a
higher expression of vimentin in GABAergic neurons. Accordingly, binding of C3bot to
GABAergic neurons was stronger than binding to glutamatergic neurons. A combinatory
treatment of glutamatergic neurons with C3bot and vimentin raised the amount of bound
C3bot to levels comparable to the ones in GABAergic neurons, thereby confirming the
specificity of effects. Overall, different surface vimentin levels between GABAergic and
glutamatergic neurons exist that mediate neurotrophic C3bot effects.
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INTRODUCTION
Monomeric GTPases of the Rho family are important cellular switches that regulate neuronal
morphology. RhoA usually functions as a negative regulator of axon outgrowth and together with
RhoB and C can be inhibited by Clostridium botulinum C3 exoenzyme (C3bot) that represents
the prototype of bacterial ADP-ribosyltransferases (Aktories and Frevert, 1987). For this reason,
C3bot and derivatives have been extensively used as tools to investigate neurite outgrowth and to
foster neuronal plasticity for the potential treatment of CNS traumas like spinal cord injuries (SCI).
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This has been investigated in different animal models (Dubreuil
et al., 2003; Boato et al., 2010; Loske et al., 2012). Moreover,
systematic reviews and meta-analyses (Watzlawick et al.,
2014), as well as clinical trials in humans, have subsequently
confirmed these findings (McKerracher and Anderson, 2013;
Fehlings et al., 2018).
Despite the lack of a classical cell-binding subunit of
C3bot (as in the case of the clostridial neurotoxins), we were
able to demonstrate that the intermediate filament protein
vimentin as well as the ß1-subunit of integrins, known
to serve as a transmembrane receptor for cell-extracellular
matrix adhesion, function as surface interaction partners for
C3bot (Rohrbeck et al., 2014, 2017; Adolf et al., 2019).
Lack of vimentin results in failure of C3bot to foster axonal
outgrowth in hippocampal/neocortical neurons as shown in
vim−/− cultures (Adolf et al., 2016). In wild type neurons
surface vimentin might originate from astrocytic exosomal
release followed by binding to neuronal membranes but
might also stem from so far unraveled neuronal trafficking
routes guiding this primarily intracellular protein to the cell
surface. Astroglial upregulation and subsequent vimentin release
in vivo has also been demonstrated by other groups in the
intact and injured CNS (Teshigawara et al., 2013; Shigyo
and Tohda, 2016). In this context, we were able to show
that exosomes obtained from cultured scratch-injured wild
type but not vim−/− astrocytes enhanced binding of C3bot
to synaptosomes from the brain and spinal cord (Adolf
et al., 2019). Generally, studies to investigate neuronal process
outgrowth and regeneration by C3bot primarily used mixed
neuronal cultures containing different neuronal subtypes as
well as co-cultured glia cells. Consequently, the observed
promoting effects of C3bot on axonal and dendritic growth
reflect the net outcome of a plethora of neuron subtypes
in the presence of glia. Also, the regeneration-promoting
CNS effects of C3bot or C3bot-derived peptides on axon
regeneration in vivo in defined neuron types such as the
primarily glutamatergic retinal ganglion cell axons in the
optic nerve (Bertrand et al., 2007; Hu et al., 2007) as
well as glutamatergic corticospinal or serotonergic descending
brainstem fibers (Boato et al., 2010) display the effects in a
glial environment.
A recently developed culturing method established to obtain
highly purified GABAergic neurons from transgenic rat andmice
(Turko et al., 2019) together with cultures of highly purified
glutamatergic neurons (Goebbels et al., 2006) now opens the
opportunity to independently analyze the sensitivity of these
two major neuron subtypes to the direct growth-promoting
effects of C3bot in the absence of glia. By crossing glutamatergic
TdTomato expressing NexCre;Ai9 and GABAergic VGAT-Venus
mice a transgenic NexCre;Ai9xVGAT-Venus mouse line was
obtained that offers the advantage to obtain highly purified
FAC sorted neuronal cultures of both neuron subtypes from
littermates or even the same animal.
The current study was undertaken, first, to determine if
putative differences in expression levels of neuronal C3bot
binding partners such as ß1-integrin and vimentin exist that
could mediate differential responsiveness to C3bot in inhibitory
and excitatory neuron types. Second, we wanted to answer
the question if neuronal vimentin, in the absence of a glial
source, is sufficient to mediate C3bot effects. Therefore, we
compared the effects of C3bot on axonal and dendritic growth
of GABAergic and glutamatergic neurons by morphometrical
analysis. Biochemically, we determined the expression levels of
vimentin and ß1-integrin as well as the ability of C3bot to bind
to these two cell types.
MATERIALS AND METHODS
Expression of Recombinant C3bot and
Vimentin Protein
Clostridium botulinum C3 protein (C3bot) was expressed as
recombinant glutathione S-transferase-fusion proteins in E. coli
TG1 harboring the respective DNA fragment in the plasmid
pGEX-2T. GST was removed by thrombin cleavage. Vimentin
expression and purification were performed as described before
(Rohrbeck et al., 2014). Plasmids of full-length mouse vimentin
provided by Prof. Dr. Yi-Ling Li, Institute of Biomedical Sciences,
Genomics Research Center, Academia Sinica, Taipei, Taiwan
were used.
Animals
VGAT-Venus-A Wistar rats that selectively express a yellow
fluorescent protein variant (Venus) in more than 95% of
cortical GABAergic neurons were used to investigate the
effects of C3bot on rat GABAergic neurons (Uematsu et al.,
2008). NexCre;Ai9 × VGAT Venus mice were bred from
NexCre;Ai9 mice (Goebbels et al., 2006; Madisen et al., 2010;
described in Turko et al., 2019) and VGAT Venus mice
(Wang et al., 2009). NexCre;Ai9 × VGAT Venus mice express
the red fluorescent protein, TdTomato, in the majority of
post-mitotic glutamatergic neurons and the yellow fluorescent
protein, Venus, in the majority of GABAergic and glycinergic
neurons. Genotyping of pups before cell culture (Figure 2A)
was done using a fluorescent head-mounted miner’s lamp
(Excitation filter FS/ULS-02B2/emission filter FS/TEF-3GY1:
BLS Ltd, Budapest, Hungary).
Cell Sorting of GABAergic and
Glutamatergic Neurons
The purification and culture of GABAergic and glutamatergic
neurons have been described previously (including a Jove
video protocol of the whole procedure, found in Turko et al.,
2019). In brief, cortico-hippocampal tissue from postnatal
(days 0–2) VGAT-Venus-A Wistar rats or NexCre;Ai9
× VGAT Venus mice (Figure 2A) was dissected and
dissociated in papain (1.5 mg/ml for 30 min). Cells were
then resuspended in Hibernate A low fluorescence transport
medium (BrainBits, Springfield, IL, USA), supplemented with
B27 (1× concentration), Glutamax (1× concentration), and
penicillin-streptomycin (100 U/ml; all sourced from Gibco,
Waltham, MA, USA). Dissociated cells were then sorted using
either BD FACSAria I or II flow cytometers, at the Flow
Cytometry and Cell Sorting Facility (FCCF) in the Deutsches
Rheuma-Forschungszentrum (DRFZ, Berlin Germany). An
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example dot plot showing the typical gating parameters used
for sorting is given in Figure 2B. Following sorting, purified
GABAergic and glutamatergic neurons were resuspended in
Neural Basal A (NBA) medium (with the same supplements as
Hibernate A medium; Thermo Fisher Scientific, Waltham, MA,
USA). For cell morphology analysis and immunocytochemistry,
purified neurons were plated onto 12mm, round, glass coverslips
in a 24-well plate, at a density of 1,000 cells/µl, 10 µl/well. For
Western blot experiments, cells were plated in six-well plates,
at a density of 500 cells/µl, 2 ml/well (1 × 106 cells per well).
Coverslips and culture plates were coated in poly-L-lysine
hydrobromide solution before plating (20 µg/ml, 1 h; Merck
Millipore, Darmstadt, Germany). Cells were grown for 4–14 days
in vitro (DIV) before direct fixation in 4% paraformaldehyde
(PFA) solution for cell morphology and immunocytochemistry
analysis or harvested without fixation for protein analysis. Cells
were incubated at 37◦C, at 5% CO2, in a humidified incubator
(Heraeus; Thermo Fisher Scientific, Waltham, MA, USA).
Antibodies
Primary Antibodies
Monoclonal mouse anti-Tau IgG (#314011, IF dilution 1:1,000,
Adolf et al., 2016), polyclonal rabbit anti-microtubule-associated
protein 2 (Map2, #188003, IF dilution 1:1,000, Troca-Marín et al.,
2011), polyclonal rabbit anti-vimentin (#172002, IF dilution
1:400, Adolf et al., 2019) and polyclonal rabbit ß1-integrin IgG
(#240003, WB dilution 1:1,000; Liu et al., 2009) were from
Synaptic Systems, Göttingen, Germany. A monoclonal rat anti-
ß1-integrin IgG (#MAB 2405, IF dilution 1:500) was from
R&D Systems (Minneapolis, MN, USA). An affinity-purified
polyclonal rabbit IgG against full-length C3bot (IF dilution
1:1,000,WB dilution 1:2,000) was developed in our lab (Rohrbeck
et al., 2014). A monoclonal mouse anti-glyceraldehyde-3-
phosphate dehydrogenase IgG (GAPDH, MAB374, WB dilution
1:4,000, Dazard et al., 2003) was fromMerck Millipore.
Secondary Antibodies
Alexa 594 goat anti-rabbit IgG (#11012, dilution 1:500), Oregon
Green goat anti-rabbit IgG (#0-11038, dilution 1:300), Oregon
Green goat anti-mouse IgG (#0-6380, dilution 1:500) were from
Invitrogen (Carlsbad, CA, USA). Alexa 647 goat anti-rabbit
IgG (#111-605-144) was from Jackson Labs, Bar Harbor,
USA. Peroxidase-conjugated horse anti-mouse IgG (#PI-2000.
Dilution 1:4,000) and goat anti-rabbit IgG (#PI-1000, dilution
1:1,000–4,000) were from Vector Laboratories, Burlingham,
NY, USA.
Immunofluorescence
Cultured neurons were fixed after 4 days in culture with 4%
formalin in 0.1 M PBS and incubated at 4◦C overnight with the
respective primary antibodies (see above). Following repeated
washing in PBS, cells were incubated for 2 h at RT with
fluorescence-conjugated secondary antibodies. Cells were again
washed and mounted with Immu-Mountr (Thermo Fisher
Scientific, Waltham, MA, USA).
For lectin-based membrane staining, an Alexa Fluor
488-conjugated wheat germ agglutinin (Thermo Fischer
Scientific, Waltham, MA, USA) was used. Typically, the
conjugate was added by a medium application at 2.5–5 µg/ml
for 10 min at 36◦C. Cells were washed 3× with PBS before
further handling. Images were acquired using epifluorescence
(see below) or using a Leica SL confocal device.
Morphometrical Analysis
Total length and the overall number of branches from
axons and dendrites, as well as axon segment orders (first
order represents the axon stem, second order the branches
originating from the first branch node and so on), were
analyzed morphometrically from images taken by a Leica DMLB
upright epifluorescence microscope using a PL FLUOTAR
40× objective using the Neurolucida software applying manual
reconstruction (MicroBrightField, Williston, VT, USA). Filter
cubes were the following: 450–490 nm excitation with a
510 nm dichromatic mirror, 515–560 nM excitation and
580 nm dichromatic mirror and 620–660 nm excitation and
660 nm dichromatic mirror for green, red, and invisible
red spectrum fluorescence, respectively. The parameter ‘‘axon
length’’ represents the integral length of all visible parts of
an axon, including branches. Typically, 30–40 neurons per
condition were randomly chosen given they exhibited a clear
morphological differentiation into the axonal and dendritic
compartment as judged mainly by the length of the neurites (see
also Figures 3A,B) and evaluated from independent experiments
that were carried out two to three times. Exact n values for
cells, coverslips, and animal numbers are given in the respective
figure legends. For morphometrical reconstruction Tau staining
was applied that exclusively marks axons in mature neurons
but also works as an excellent antibody to stain neurites up
to the fine branches of both the axonal and the dendritic
compartment in immature neurons used in our study. Providing
there were no significant differences between coverslip means
(means of the axon and dendrite parameters from individual
coverslips), data were pooled and given as mean ± SEM.
Unless otherwise stated, a Student’s t-test was used to test for
significance between means [significance: 0.05 (*), 0.01 (**), and
0.001 (∗∗∗)].
C3 Binding Assays
To biochemically assess C3 binding, cultured neurons were
first grown for 7 days in vitro (DIV). Typically, 2–5 × 106
neurons were used per condition, in each experiment. To test
for C3bot interaction with specific neuron types, cell culture
supernatant was first discarded and cells were harvested in PBS.
Suspended cells were exposed to 300 nM of C3bot for 1 h at
4◦C with or without addition of 1 ng/µl recombinant vimentin.
Subsequently, cells were washed two times with PBS. Cells were
then pelleted and transferred into the Laemmli sample buffer
for gel electrophoresis and blotting. For immunocytochemical
analysis of C3bot binding, purifiedGABAergic and glutamatergic
neurons were cultured together in a 50:50 mix (500 cells YFP
and 500 cells RFP/µl in a 10 µl droplet—total cells = 10 × 104
cells/coverslip). Cells were grown to 7 DIV before 1-h treatment
with 300 nM C3bot (4◦C). Cells were then washed twice in PBS
before fixation and processing for immunocytochemistry.
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RESULTS
To investigate whether C3bot affects GABAergic interneurons
in the absence of glial cells, we first analyzed GABAergic
neuronal cultures obtained from VGAT-Venus-A Wistar rats
FAC sorted cultures of these animals selected for Venus-positive
cells contain 99% of GABAergic neurons (Turko et al., 2019).
FAC sorted cultures of these animals selected for Venus-positive
cells contain 99% of GABAergic neurons (Turko et al., 2019).
For a readout, we looked at the morphological effects elicited
by medium application of Clostridium botulinum C3 transferase
(C3bot) on neocortical/hippocampal neurons prepared from
early postnatal brains. Initially, we started with analyzing the
C3bot-mediated effects on neurite formation and early growth
during the first 72 h (Figures 1A,B). After 24 h in culture,
the majority of cells presented as unipolar neurons with no
significant effects of C3bot observable. A day later C3bot had
significantly lowered the number of unipolar neurons but raised
the proportion of multipolar cells. After 72 h the majority of
control cells exhibited either a bipolar (50%) or multipolar
(40%) morphology. Treatment with C3bot, on the other hand,
promoted the formation of multipolar cells that represented the
vast majority of neurons (80%) while the number of bipolar
cells was reduced to 20%. Next, we analyzed the overall length
of the neuronal processes (Figure 1C). Starting from 48 h of
incubation, C3bot treatment resulted in a significant promotion
of process growth reaching nearly +175% after 72 h. To see
whether the effect of an increased process formation resulted
from enhanced dendrite formation in C3bot-treated neurons
we stained the neurons for the dendritic marker microtubule-
associated protein 2 (Map2) and counted the number of dendritic
processes. The morphometrical analysis indeed revealed a
significantly increased number of dendrites in treated neurons
(Figure 1D). Differential analysis of dendritic vs. axonal effects
(only neurons showing a clear morphological differentiation
in a dendritic and axonal compartment, see also Figure 3A
for general criteria applied, were analyzed) revealed that both
dendritic and axonal growth contributed to the observed effect
(Figures 1D,E).
Taken together, the results demonstrate a direct and
glia-independent growth-promoting effect of C3bot on a defined
subpopulation of neurons, namely neocortical/hippocampal
GABAergic interneurons.
We then asked whether different subtypes of neurons
exhibit differential sensitivity to the inhibition of rho-mediated
pathways by C3bot. To this end we used newly established
transgenic NexCre;Ai9xVGAT Venus mice that offer the
opportunity to obtain purified GABAergic and glutamatergic
neurons from a single animal line or even individual animals.
Consequently, this allows for a direct comparison of C3bot
effects on these neuronal subtypes. Animals of glutamatergic
NexCre;Ai9-x and GABAergic VGAT-Venus lines were crossed.
NexCre;Ai9xVGAT-Venus positive mice were identified by
transcranial detection of red and green fluorescence expression
after birth using a fluorescent lamp (Figure 2A). A large number
of glutamatergic neurons such as the pyramidal cells in the
neocortex together with the GABAergic interneurons exhibited
a red/orange fluorescence, while the cerebellum appeared green
due to a large number of GABAergic neurons in the Purkinje
cell layer and Golgi cells in the molecular layer. Following
cell sorting (Figure 2B) Venus and TdTomato expressing
neurons were enriched to high purity and cultured in isolation
(Figure 2C).
Separate cultures of fluorescent Venus (GABAergic) or
TdTomato (glutamatergic) neurons obtained by this procedure
were used for themorphometrical measurements of C3bot effects
on specific neuronal subtypes. To quantify the morphological
effects elicited by C3bot we first used GABAergic neurons
incubated for 72 h with 300 nM of C3bot. For visualization,
endogenous Venus fluorescence was combined with staining
for Tau to identify both the axon and dendrites to the finest
branches. Tau represents an established axonal marker in
cultured mature neurons (Kosik and Finch, 1987) but in the
case of the immature neurons used in our study Tau has not
yet fully disappeared from dendrites. After 4 days in culture,
the vast majority of purified GABAergic neurons had developed
a single long process that by characteristic morphological
parameters- primarily the length- but also others such as
more extensive branching and initial small diameter was easily
discernable from dendrites (Figures 3A,B). Morphometrical
measurements revealed a C3bot-mediated increased axonal
length by 83% (Figures 3C,D). Axonal branching was even
more enhanced up from second segment order branches with
a total increase of axon nodes by 138% (Figures 3D,E).
Analysis of dendrite growth and branching (Figure 3F)
revealed C3bot-mediated promoting effects on total dendrite
length by 115%, the individual dendrite length was raised
by 69%, the number of dendrites by 27%, and the at this
maturation stage still poorly developed dendritic branch nodes
by 333%. These data supported our previous findings in the
rat model.
We then applied the same criteria for a morphometrical
analysis using purified TdTomato expressing glutamatergic
neurons (Figure 4A). The axonal length was increased by 62%
following C3bot treatment (Figure 4B). Axonal branching was
also enhanced up from second segment order branches with a
total increase of axon nodes by 70% (Figures 4B,C). Analysis
of dendrite growth and branching revealed significant yet lower
C3bot-mediated effects on total dendrite length of 49%, and
individual dendrite length of 24%. In contrast to GABAergic
neurons, the number of dendrites as well as their branching were
not altered (Figure 4D).
In summary, regarding most parameters investigated
GABAergic neurons exhibited a higher sensitivity to the
neurotrophic effects elicited by C3bot than glutamatergic ones
(for a summary, see Table 1).
So far, two binding partners for C3bot have been identified.
The first protein discovered by our group was vimentin which
represents an intracellular protein but appears also at the
cell surface (Rohrbeck et al., 2014). The second interacting
protein residing at the plasma membrane was identified as
the ß1-subunit of integrin (Rohrbeck et al., 2017). In the
light of these findings, we checked for putative differences in
the expression levels of these two proteins in GABAergic vs.
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FIGURE 1 | C3bot fosters dendrite formation and outgrowth and enhances axon length of purified rat GABAergic neurons. (A) Representative images of GABAergic
neurons stained for α-tubulin displaying the respective morphologies at the indicated time points. Images not to scale. (B) Positive-sorted GABAergic neurons
obtained from VGAT-Venus rats were incubated at low density for 24, 48, or 72 h (DIV1–DIV4) with or without 300 nM of C3bot application. Bar charts summarizing
the effect of C3bot on GABAergic cell morphology over time. After 48 h, C3bot-treated neurons showed a significantly enhanced proportion of multipolar cells
paralleled by a reduced number of unipolar cells. One day later, C3bot-treated cells had increased the multipolar phenotype 2-fold compared to control neurons,
(Continued)
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FIGURE 1 | Continued
reflected by a decreased proportion of bipolar, unipolar, and cells bearing no
processes. (C) Fixed cells were subjected to morphometrical analysis of
overall process length after 24, 48, or 72 h of incubation with 300 nM of
C3bot. Significant promoting effects were observed after 48 h and, more
pronounced, after 72 h of treatment. (D) Fixed cells were subjected to
morphometrical analysis of dendrite number and overall dendrite length after
72 h of C3bot incubation. Map2 staining was used to support the
differentiation of neuronal processes into dendritic and axonal (arrowheads)
compartments. Both parameters were significantly increased by C3bot
compared to untreated cells. (E) Axon growth was also analyzed and revealed
the promoting effect of C3bot on axon length. Data represent the means
±SEM. Statistical differences were determined by Student’s t-test (*p ≤ 0.05;
**p ≤ 0.01; ***p ≤ 0.001). For 24, 48, and 72 h incubation time, data were
obtained from a total of 251, 331, or 161 neurons, respectively. Per condition,
cells from three individual coverslips and two animals were evaluated.
glutamatergic neurons that could account for the differential
sensitivity of these two neuron subtypes to C3bot. First, we
aimed to detect the expression of vimentin and ß1-integrin by
using immunofluorescence methods in mixed purified cultures.
Both GABAergic and glutamatergic neurons exhibited detectable
levels of either protein when co-cultured (Figures 5A,B).
Next, we performed qualitative immunofluorescence binding
assays using C3bot in mixed GABAergic/glutamatergic cultures.
Application of 300 nM of C3bot for 1 h at 4◦C revealed a
stronger binding of C3bot to GABAergic than glutamatergic
neurons (Figure 5C). To allow for a better comparison of
the protein levels we performed Western blot assays and
stained culture homogenates for vimentin and ß1-integrin in
isolated sorted cultures (Figures 5D,E). Whilst ß1-integrin
was detected at similar levels in both neuron types vimentin
showed a marked reduction of 50% in glutamatergic neurons
FIGURE 2 | Generation of purified GABAergic and glutamatergic cell cultures using fluorescence-based cell sorting. (A) Images showing the fluorescent signal from
transgenic NexCre;Ai9xVGAT Venus mice at postnatal day 2. The Neocortex appears strongly positive for TdTomato, due to the large numbers of glutamatergic
neurons in this area. The cerebellum appears strongly positive for Venus, due to the large numbers of Purkinje and other GABAergic neurons in the molecular layer.
(B) Intensity scatter plot of NexCre;Ai9xVGAT Venus dissociated cortico-hippocampal cells. Strongly fluorescent TdTomato (glutamatergic) or Venus (GABAergic)
cells were selected for sorting (see gating boxes). (C) Combined infrared (bright field) images and superimposed fluorescent signals from living TdTomato (left) and
Venus (right) positive neurons after 1 h in vitro.
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FIGURE 3 | C3bot-mediated neurotrophic effects on purified GABAergic neurons. (A) Positive-sorted GABAergic neurons obtained from NexCre;Ai9x VGAT Venus
mice were grown at low density for 72 h (DIV1–DIV4), fixed and immunostained for Tau indicating neuronal morphology. Most neurons had developed processes
differentiated into a single axon (white arrowhead) and several dendrites. (B) GABAergic neurons at higher magnification. A single axon (white arrowhead) and several
shorter tapering dendrites (black arrowheads) extend from the soma. (C) Positive-sorted GABAergic neurons were grown at low density for 72 h (DIV1–DIV4) with or
without 300 nM of C3bot application. Following incubation, cells were fixed and immunostained for Tau strongly labeling axons and dendrites. A GABAergic cell
phenotype was ascertained from endogenous Venus expression. (Arrowhead: axon, D) Fixed cells were subjected to morphometrical analysis of axon length and
(Continued)
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FIGURE 3 | Continued
branch nodes. Both parameters were significantly increased by C3bot
treatment relative to controls. (E) Axon segment order analysis revealed that
treatment with C3bot increased branching up from second-order branches.
(F) Morphometrical analysis of dendrite parameters. Treatment with C3bot
resulted in increased dendritic length, number, and branch nodes. Data
represent the means ± SEM. Statistical differences were determined by
Student’s t-test (*p ≤ 0.05; ***p ≤ 0.001). Per condition, a representative
analysis of a total of 40 neurons from four individual coverslips and two
animals is displayed.
compared to GABAergic cells. To answer the question of whether
the higher vimentin expression in GABAergic neurons was also
accompanied by enhanced binding of C3bot to this neuron
subtype we performed binding assays in the same cultures
used to detect vimentin and ß1-integrin levels. Incubation of
GABAergic and glutamatergic neurons with 300 nM at 4◦C for
1 h revealed a 30% reduction of C3bot binding to glutamatergic
neurons compared to GABAergic cells. To test whether the
decreased binding of C3bot could be restituted by the addition
of vimentin to glutamatergic neurons we added recombinant
vimentin (1 ng/µl) while binding of C3bot was performed
(Figure 5F). Quantification revealed that the combinatory
treatment of glutamatergic neurons with C3bot and vimentin
equalized the amount of bound C3bot in both neuron types,
thereby confirming that the observed differences in binding were
due to the different vimentin levels.
To demonstrate surface localization of vimentin in
GABAergic neurons, living neurons were lectin-treated
for 10 min with Alexa488-coupled wheat germ agglutinin
(WGA488) to label the plasma membrane. This procedure
was then followed by fixation and antibody staining against
vimentin in either permeabilized or unpermeabilized cells
(Figure 5G). In contrast to permeabilized cells, unpermeabilized
FIGURE 4 | C3bot-mediated neurotrophic effects on purified glutamatergic neurons. (A) Positive-sorted glutamatergic neurons were grown at low density for 72 h
(DIV1–DIV4) with or without 300 nM C3bot application. Following incubation, cells were fixed and immunostained for Tau as an axonal marker. A glutamatergic cell
phenotype was ascertained by endogenous TdTomato expression. (Arrowhead: axon, B) Fixed cells were subjected to morphometrical analysis of axon length and
branch nodes. Both parameters were significantly increased by C3bot treatment relative to controls. (C) Axon segment order analysis revealed that treatment with
C3bot increased branching up from second-order branches. (D) Morphometrical analysis of dendrite parameters. Treatment with C3bot resulted in increased
dendritic length. Data represent the means ± SEM. Statistical differences were determined by Student’s t-test (*p ≤ 0.05). Per condition, a representative analysis of
a total of 30 neurons from three individual coverslips and two animals is displayed. **p ≤ 0.01; ***p ≤ 0.001.
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TABLE 1 | Summary of C3bot effects on the morphology of GABAergic and glutamatergic neurons.
Axon length Axon nodes Dendrite length Mean dendrite length Dendrite nodes Number of dendrites
Sorted GABAergic neurons 183%(*) 237, 6%(*) 215%(*) 168, 9%(*) 433% 127, 2%
Sorted glutamatergic neurons 161, 7% 170% 149, 4% 124, 3% 133, 32% (n.s.) 107, 23% (n.s.)
Values are given in % of untreated control cells. Asterisks behind effects on GABAergic neurons indicate statistical significance over effects on glutamatergic neurons (*p ≤ 0.05). n.s.:
not significant effects within glutamatergic neurons.
GABAergic neurons exhibited a strongly reduced intracellular
vimentin signal and a clearly visible co-localization with
the WGA488 signal, thus indicating a surface or at least
surface-near localization.
In summary, by using a novel transgenic mouse line,
the present work demonstrates a differential sensitivity of
GABAergic vs. glutamatergic neurons towards the growth-
promoting effects of Clostridium botulinum C3 protein that is
mediated by vimentin.
DISCUSSION
Vimentin has been demonstrated to function as a key
neuronal cell-binding partner for clostridial C3 transferase.
In neuronal cell lines such as hippocampal HT22 cells as
well as J744A.1 macrophages surface vimentin was the first
protein identified to interact with C3bot during the process of
cell binding and uptake thereby eliciting its cellular responses
(Rohrbeck et al., 2014, 2015). Using a knockout strategy,
vimentin was shown to be crucially involved in mediating the
growth-promoting effects of C3bot in hippocampal/neocortical
neurons (Adolf et al., 2016). In addition to this, site-directed
mutagenesis creating mutant C3bot variants with a disturbed
RGD integrin-binding domain further identified the ß1-integrin
subunit as an additional binding partner for C3bot in neuronal
cell lines, macrophages, and primary neuron cultures (Rohrbeck
et al., 2017).
Vimentin, besides its role in the formation of the intracellular
intermediate filament system, has gained recent attention as
a surface-expressed protein, providing a docking structure
for invading pathogens in a variety of cell types, amongst
them the SARS-associated coronavirus (Mak and Brüggemann,
2016; Yu et al., 2016). Also, this surface expression has been
linked to malignant tumor progression (Liu et al., 2020).
Various posttranslational modifications such as citrullination
or phosphorylation are involved in the regulation of vimentin
secretion into the extracellular fluid or in mediating surface
presentation in different cell types (for review see Patteson et al.,
2020). Also, conformational changes have been identified that
elucidate mechanisms of membrane integration as a prerequisite
for surface location. In this context, it was demonstrated that
vimentin presents as oligomers (4–12mers) rather than filaments
at the surface of glioma cells (Hwang and Ise, 2020). The
same group had shown before that the K373-G407 residues of
the rod II domain bind N-acetylglucosamine and represent a
lectin-like cell surface-exposed domain (Ise et al., 2010). On
the neuronal surface, the insulin-like growth factor-1 receptor
(IGF1R) represents a binding partner for extracellular vimentin
that upon activation by vimentin fosters axonal outgrowth in
cortical neurons (Shigyo et al., 2015). Current investigations by
our group address the question of whether similar mechanisms
to the ones found in macrophages, endothelial cells, glioma, or
astrocytes that release vimentin by exosomal secretion (Adolf
et al., 2019) also exist in neurons. In the developing brain
neuronal vimentin is gradually replaced by neurofilaments
representing the main intermediate filament system of the
mature axon (Li et al., 2013). During the transition from the
premature to the differentiated neuron, vimentin was found to
bemainly associated with hypophosphorylated neurofilaments to
form heteropolymers and to become excluded from extensively
phosphorylated neurofilament bundles. In contrast to the
vimentin/neurofilament heteropolymers, these bundles stabilize
and become resistant to proteolytic cleavage and therefore
vimentin is gradually removed from the neurites (Yabe et al.,
2003). Generally, the upregulation of (mainly astroglial) vimentin
is well documented following CNS lesions in various systems
(Pekny and Pekna, 2016). Concomitant with the upregulation,
release of glial vimentin to the extracellular space and binding
to neuronal membranes may occur (Teshigawara et al., 2013;
Shigyo et al., 2015; Shigyo and Tohda, 2016; Adolf et al.,
2019). Upregulation of neuronal vimentin, on the other hand,
may also take place since it was observed in lesioned sciatic
nerve fibers (Perlson et al., 2005) as well as in neurons of
the cerebral cortex, cerebellum, and hippocampus affected by
Alzheimer’s disease (Levin et al., 2009). In line with this, the
injection of kainate into the rat spinal cord resulted in the
prolonged neuronal upregulation of vimentin (Nishida et al.,
2017). Interestingly, the expression of neuronal vimentin by
transfection of differentiated neuroblastoma cells with vimentin
resulted in an enhanced axon outgrowth (Dubey et al.,
2004). Overall, damage-associated upregulation of vimentin is a
proposed response mechanism that recapitulates earlier stages
in neuronal development crucial for differentiation and fast
process outgrowth. The presentation of an increased amount of
extracellular vimentin might be therefore advantageous for the
regeneration-promoting properties of C3bot when used as a tool
to foster axonal or dendritic re-growth.
Cultured neurons are usually obtained from embryonic or
early postnatal days and seem to resemble developing neurons
in the in vivo situation since they usually express vimentin
throughout their culture period (own observations). We here
report on a differential expression profile of the intermediate
filament protein vimentin but not ß1-integrin between the
two major classes of cortical neurons, the projecting excitatory
neurons, and the inhibitory interneurons.
Both cell types differ in many anatomical and physiological
properties. Moreover, diversity within the lineages of
excitatory and inhibitory neurons exists in a way that
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FIGURE 5 | Higher vimentin levels in purified GABAergic neurons are accompanied by increased binding of C3bot. Purified GABAergic and glutamatergic neurons
were mixed at a 1:1 ratio and cultured together for 5 days, fixed and immunostained for (A) vimentin or (B) ß1-integrin using an Alexa647-conjugated secondary
antibody. Prior staining of living cells with Alexa-488 conjugated wheat germ agglutinin (WGA488) was used to mark neuronal membranes. TdTomato expression
was used to discern glutamatergic from GABAergic cells. Both vimentin and ß1-integrin were expressed at detectable levels in either cell type in the soma and
throughout the processes. (C) Purified mixed neurons were cultured together for 5 days. Cells were then incubated with 300 nM of C3bot for 1 h at 4◦C.
(Continued)
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FIGURE 5 | Continued
Following washing and fixation cultures were stained for bound C3bot. A
comparison between Venus expressing GABAergic and TdTomato expressing
glutamatergic neurons revealed a stronger association of the C3bot signal
(detected by an Alexa 647-coupled secondary antibody) with GABAergic
neurons. (D) Separate GABAergic and glutamatergic neuron cultures were
incubated with 300 nM of C3bot for 1 h at 4◦C. Western blot analysis was
performed to detect endogenous ß1-integrin and vimentin as well as bound
C3bot. GAPDH was used as a loading control. (E) A quantitative analysis of
the blots shown in (D) revealed equal amounts of ß1-integrin, but strongly
reduced vimentin levels in glutamatergic neurons compared to GABAergic
cells. Accordingly, C3bot binding also was reduced in glutamatergic cells.
Data represent the mean of three independent experiments ± SEM.
Statistical differences were determined by Student’s t-test (*p ≤ 0.05; **p ≤
0.005). (F) Binding assays were performed as in (D), not (C) using a modified
combinatory treatment with 300 nM C3bot and recombinant vimentin at
1 ng/µl in glutamatergic neurons. Differences in C3bot binding were no longer
observable. Data represent the mean of three independent experiments
±SEM. (C–E) Data were obtained from three individual experiments. (G)
Depicted are GABAergic neurons at DIV 5 in mixed culture stained live with
WGA488 to mark the plasma membrane. Cells were then fixed and stained
for vimentin (Alexa 647-coupled secondary antibody) under permeabilizing
(standard) or non-permeabilizing conditions. Insets show vimentin
co-localizing with the WGA488 signal in an unpermeabilized GABAergic
neuron. (A,B,G): confocal imaging.
neocortical excitatory neurons derive from progenitors in
the pallium whereas GABAergic interneurons derive from
progenitors in the subpallium (Marín and Müller, 2014).
Inhibitory GABAergic interneurons in vivo comprise only
10–20% of the neuronal population but are characterized
by a dense local axonal arbor that coordinates the
activity of large populations of local neurons (Booker and
Vida, 2018). Despite their relatively low number, they
are the most diverse neurons in terms of morphology,
connectivity, and physiological properties (Ascoli et al., 2008;
Kepecs and Fishell, 2014).
Remarkably, the observed axonotrophic effects of C3bot are
more pronounced in GABAergic interneurons even though
glutamatergic layer V excitatory neurons, for example, can
project to very distant spinal projection areas. The exact
reason for the higher vimentin expression in GABAergic
neurons remains to be elucidated. Despite the anatomical
and physiological differences between inhibitory and excitatory
neurons, we could show by the addition of extracellular vimentin
that the detected differential sensitivity to C3bot was indeed
due to the different vimentin levels. Other integrins such
as the β3-subunit have been identified to directly interact
with vimentin and to enhance the surface presentation of
vimentin at endothelial focal adhesion sites (Bhattacharya et al.,
2009). On the other hand, filamentous vimentin underneath
the plasma membrane can regulate integrin-ligand interactions
by binding to the β3-subunit (Kim et al., 2016). Differential
expression profiles of β1-integrins, however, seem not to be
responsible for the enhanced vimentin levels in GABAergic
neurons or directly account for an increased cell binding
of C3bot.
Further work addressing the in vivo neuronal growth-
and regeneration-promoting properties of C3bot in vimentin
knockout mice will add to the understanding of the cellular
mechanisms underlying the observed neurotrophic effects.
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